Capsugel Names New Business Development Manager For Dietary Supplement Business

March 5, 2008 – Capsugel, a global leader in dosage form development and manufacturing, today announced the appointment of Arthur Radcliffe to Business Development Manager, Dietary Supplements, Americas region.

Radcliffe is charged with developing growth strategies for Capsugel’s dietary supplement business. In addition to overseeing the pending launch of Vcaps® Plus capsules, a new plant-based capsule composed of HPMC, Arthur’s focus will include building customer programs based on industry trends and emerging markets, as well as forming strategic partnerships for development of new customer products and services.

“Arthur has a distinguished track record in the area of business growth for Capsugel,” said Brad Larson, Manager of Marketing and Business Development for the Americas region. “He has a talent for developing customer loyalty and service, and an instinct for recognizing new ideas and market opportunities. We believe our customers will benefit greatly from his reputation and experience in the industry.”

Since joining Capsugel in 1995, Radcliffe has played important roles that have helped increase Capsugel’s market share in the dietary supplement market. He has been awarded several company achievement awards for outstanding performance.

Before joining Capsugel, Radcliffe received a Bachelor of Science degree in business administration from Lander University. He served in the United States Navy from 1984 to 1991.

# # #

Capsugel, a world leader in dosage form development and manufacturing, produces two-piece gelatin and vegetarian capsules for nutraceutical, pharmaceutical and over-the-counter (OTC) markets. The Capsugel product line of uniquely designed and patented products includes Licaps® liquid capsules, Vcaps® and Vcaps® Plus vegetarian capsules, and DBcaps® capsules for double-blind clinical trials. The company also customizes liquid-fill formulas with laboratories in both the US and Europe. Capsugel is a division of Pfizer Inc. For more information, visit, or call (864) 942-3063

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.